1. Home
  2. NATL vs RCKT Comparison

NATL vs RCKT Comparison

Compare NATL & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Atleos Corporation

NATL

NCR Atleos Corporation

HOLD

Current Price

$45.51

Market Cap

3.4B

Sector

N/A

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$2.59

Market Cap

394.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NATL
RCKT
Founded
2023
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
394.2M
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
NATL
RCKT
Price
$45.51
$2.59
Analyst Decision
Hold
Buy
Analyst Count
4
14
Target Price
★ $45.60
$29.73
AVG Volume (30 Days)
543.0K
★ 1.6M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 73.98
26.37
EPS
★ 1.15
0.66
Revenue
★ $4,354,000,000.00
N/A
Revenue This Year
$6.13
N/A
Revenue Next Year
$4.24
$64.28
P/E Ratio
$39.54
★ $3.91
Revenue Growth
★ 0.86
N/A
52 Week Low
$33.31
$2.51
52 Week High
$48.50
$5.45

Technical Indicators

Market Signals
Indicator
NATL
RCKT
Relative Strength Index (RSI) 42.04 27.41
Support Level $45.40 N/A
Resistance Level $46.12 $3.67
Average True Range (ATR) 0.52 0.23
MACD -0.03 -0.11
Stochastic Oscillator 11.76 5.62

Price Performance

Historical Comparison
NATL
RCKT

About NATL NCR Atleos Corporation

NCR Atleos Corp is a financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers, and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels, all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware, and its proprietary Allpoint network. Atleos manages its operations in the following segments: Self-Service Banking, which generates maximum revenue, Network, and Telecommunications and Technology. Geographically, it derives maximum revenue from the U.S.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: